Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared

Status Terminated

Clinical Trial Summary

A randomized, crossover, open study in order to compare treatment satisfaction with insulin Glargine plus insulin Apidra Vs NPH insulin plus insulin Apidra in newly diagnosed children and adolescents with type 1 diabetes.

The study will include two consecutive periods: 2 weeks run in period and 24 weeks intervention period, divided into two separate treatment periods of 12 weeks. According to randomization, each patient will be treated consecutively with both treatment arms: 12 weeks with insulin Glargine and than 12 weeks with NPH insulin or 12 weeks with insulin NPH ad than 12 weeks with insulin Glargine. Patients will complete DTSQ (Diabetes Treatment Satisfaction Questionnaire) at months 0, 12 and 24 weeks, before and at the end of each study arm.

Clinical Trial Description

A randomized, crossover, open study in order to compare treatment satisfaction with insulin Glargine plus insulin Apidra Vs NPH insulin plus insulin Apidra in newly diagnosed children and adolescents with type 1 diabetes.

134 Patients with new onset Diabetes type 1, diagnosed 12 months previously at maximum will be enrolled.

The study will include two consecutive periods: 2 weeks run in period and 24 weeks intervention period, divided into two separate treatment periods of 12 weeks. According to randomization, each patient will be treated consecutively with both treatment arms: 12 weeks with insulin Glargine and than 12 weeks with NPH insulin or 12 weeks with NPH insulin and than 12 weeks with insulin Glargine.

The study will consist of 4 clinical visits, taking place at -2, 0, 12 and 24 weeks. Height,weight,vital signs, HbA1c and insulin doses will be determined during the clinical visits.

Patients will complete DTSQ (Diabetes Treatment Satisfaction Questionnaire) at months 0, 12 and 24 weeks, before and at the end of each study arm.

The DTSQ questionnaires consists of DTSQ parents- for patients below the age of 13, and DTSQ teen for those above age 13. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00925977
Study type	Interventional
Source	Rabin Medical Center
Contact
Status	Terminated
Phase	N/A
Start date	July 2009
Completion date	February 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02546401` - Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump	Phase 3
Enrolling by invitation	`NCT06207838` - Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump	N/A
Withdrawn	`NCT02057497` - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms	N/A
Active, not recruiting	`NCT05088616` - Native American Diabetes Project	N/A
Withdrawn	`NCT01501032` - Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes	Phase 1
Completed	`NCT01770561` - Feasibility Study of an Integrated Sensor and Infusion Set	N/A
Completed	`NCT00417131` - Imaging of Islet Transplantation With PET and MRT	N/A
Completed	`NCT03538106` - Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
Completed	`NCT01565824` - Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)	N/A
Recruiting	`NCT04257877` - Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
Withdrawn	`NCT01322321` - ACZ885 in Type 1 Diabetes Mellitus	Phase 2
Active, not recruiting	`NCT04794283` - Antenatal Hand Milking for Pregnant Women With Diabetes'
Completed	`NCT03842683` - CGM Precision and Glycaemic Variability
Suspended	`NCT04874532` - A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia	N/A
Completed	`NCT02066350` - Cardiovascular Risk Factors After Single Pancreas Transplantation	N/A
Completed	`NCT02137174` - Home and School Visits Intervention for Children With DM TYPE 1	Phase 2/Phase 3
Completed	`NCT06365255` - National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes
Completed	`NCT03433677` - A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes	Phase 3
Completed	`NCT04587297` - Food Collection From Type 1 Diabetic Patients Practicing Insulin Functional Therapy
Completed	`NCT02490124` - The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms